Correlation Between Hookipa Pharma and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Nuvectis Pharma, you can compare the effects of market volatilities on Hookipa Pharma and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Nuvectis Pharma.
Diversification Opportunities for Hookipa Pharma and Nuvectis Pharma
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hookipa and Nuvectis is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Nuvectis Pharma
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Nuvectis Pharma. In addition to that, Hookipa Pharma is 1.27 times more volatile than Nuvectis Pharma. It trades about -0.22 of its total potential returns per unit of risk. Nuvectis Pharma is currently generating about -0.14 per unit of volatility. If you would invest 515.00 in Nuvectis Pharma on September 27, 2024 and sell it today you would lose (50.00) from holding Nuvectis Pharma or give up 9.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hookipa Pharma vs. Nuvectis Pharma
Performance |
| Timeline |
| Hookipa Pharma |
| Nuvectis Pharma |
Hookipa Pharma and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Nuvectis Pharma
The main advantage of trading using opposite Hookipa Pharma and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |